LAHO!July the OS numbers will reflect on OTC. Appears the scope and plan is diverse and larger than say a single pilot or product.
.. between 2005 and 2013, there has been a 300% increase in the number of diseases that can be treated by stem cells.
UK alone
GSCG technology, labs, Patient care, therapy, facility go live, certification..it all adds up. Millions of folks with health concerns, heart, cancer, hairless and other diseases.
..735,000 Americans have a heart problem...Europe..is the second largest global stem cell therapy market..1.4million people register for donating stem cell in 2017. Also, more than 2,200 searches for a lifesaving stem cell transplant were made in 2017 by UK people. ..According to the American Cancer Society, Inc 2018, report China 48.9%, India 16.2%, Japan 11.2% accounts of cancer cases in this region.
..Market representation..Revenue in USD Billion and CAGR from 2019 to 2025
Application Outlook (Revenue, USD Billion, 2014 - 2025)
Regenerative Medicine
Neurology
Orthopedics
Oncology
Hematology
Cardiovascular and Myocardial Infraction
Injuries
Diabetes
Liver Disorder
Incontinence
Others
Drug Discovery and Development
Technology Outlook (Revenue, USD Billion, 2014 - 2025)
Cell Acquisition
Bone Marrow Harvest
Umbilical Blood Cord
Apheresis
Cell Production
Therapeutic Cloning
In-vitro Fertilization
Cell Culture
Isolation
Cryopreservation
Expansion and Sub-Culture
Therapy Outlook (Revenue, USD Billion, 2014 - 2025)
..In the global stem cells market a sizeable proportion of companies are trying to garner investments from organizations based overseas. This is one of the strategies leveraged by them to grow their market share. Further, they are also forging partnerships with pharmaceutical organizations to up revenues. ..As per a report by Transparency Market Research, the global market for stem cells is expected to register a healthy CAGR of 13.8% during the period from 2017 to 2025 to become worth US$270.5 bn by 2025. Global Stem Cells Market, by Product Type